Skip to main content

Sands Capital Ventures — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

99
Companies
$4.1B
Total invested
$49.9M
Avg. check
63
Industries
Health Care 9Artificial Intelligence (AI) 9Biotechnology 6Software 5Health Diagnostics 4Machine Learning 4+57 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 99
Red Sift
March 2026

Red Sift's Digital Resilience Platform protects your perimeter, your brand and your supply chain.

Big Data · LondonNon-equity Assistance
Nanoview Biosciences
March 2022

Nanoview Biosciences is developing proprietary products that support research, translation and delivery of precision medicine.

Biotechnology · Boston$2.5M Debt Financing
Dreadnode
February 2025

Dreadnode provides advanced offensive AI tools utilized by red teams, researchers, and model builders globally.

Artificial Intelligence (AI) · Bozeman$14.0M Series A
Speech Graphics
February 2022

Speech Graphics is a graphics company that is pioneering facial animation technology for the entertainment industry.

Animation · Edinburgh$7.0M Series A
Chronicle Studios
June 2025

Chronicle Studios operates as an entertainment company.

Artificial Intelligence (AI) · Sydney$11.6M Seed
Spyglass Pharma
June 2025

Spyglass Pharma provides medicine for ophthalmic diseases.

Delivery · Aliso Viejo$75.0M Series D
Hawk
April 2025

AI based, real-time Anti Money Laundering (AML) detection, Fraud Prevention, Sanction Screening.

Artificial Intelligence (AI) · Munich$56.0M Series C
pgEdge
March 2025

pgEdge offers distributed PostgreSQL to deliver high availability and reduced data latency for mission-critical applications.

Cloud Data Services · Alexandria$4.2M Seed
CompScience
February 2025

CompScience provides AI-driven insights for workers' compensation insurance and safety.

Artificial Intelligence (AI) · San Francisco$27.6M Series B
FIRE1
January 2025

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

Biotechnology · Dublin$120.0M Venture - Series Unknown
Vitara Biomedical
November 2024

Vitara Biomedical develops a therapeutic platform to support premature infants.

Child Care · Philadelphia$50.0M Series B
Earli
August 2024

Earli develops genetic constructs for early cancer detection and targeted therapy.

Biotechnology · South San FranciscoVenture - Series Unknown
Credo AI
July 2024

Credo AI is an AI governance platform that automates AI oversight and risk management.

Artificial Intelligence (AI) · Palo Alto$21.0M Series B
Boom Entertainment
July 2024

Boom Entertainment is a technology company developing a sports gaming application focusing on casual games for the sports betting industry.

Casino · New York$5.2M Venture - Series Unknown
SeLux Diagnostics
April 2024

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Biotechnology · Charlestown$48.0M Series D
Uhnder
February 2024

Uhnder develops a digital automotive radar-on-chip designed to automate systems for safety and better feedback response.

Apps · Austin$50.0M Series D
HealthSnap
February 2024

HealthSnap is a virtual care management platform for chronic disease management.

Health Care · Miami$25.0M Series B
Day Zero Diagnostics
September 2023

The future of infectious disease diagnostics starts at Day Zero.

Biotechnology · Boston$16.0M Venture - Series Unknown
Bridgit
July 2023

Bridgit is a workforce intelligence and planning tool for the construction industry.

Big Data · Kitchener$5.3M Venture - Series Unknown
Cleerly
December 2024

Cleerly is a digital healthcare company that offers heart disease diagnosis solutions.

Apps · Denver$106.0M Series C
G-P/Globalization Partners
January 2022

GP enables international companies to hire teams without setting up branch offices or subsidiaries.

Compliance · Boston$200.0M Private Equity
Codoxo
December 2025

Codoxo leverages advanced generative and self-learning AI to enhance payment integrity in healthcare.

Analytics · Duluth$35.0M Series C
PolyAI
December 2025

PolyAI develops conversational artificial intelligence software that enables organizations to automate customer service interactions.

Artificial Intelligence (AI) · San Francisco$86.0M Series D
Mekonos
November 2021

Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip.

Biotechnology · Alameda$25.0M Series A

Where Sands Capital Ventures invests

Health Care9
Artificial Intelligence (AI)9
Biotechnology6
Software5
Health Diagnostics4
Machine Learning4

About Sands Capital Ventures's portfolio

How many companies has Sands Capital Ventures invested in?

Sands Capital Ventures has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Sands Capital Ventures invest in?

Sands Capital Ventures's top investment sectors include Health Care, Artificial Intelligence (AI), Biotechnology, Software, Health Diagnostics. The firm invests across 63 different industry categories.

What is Sands Capital Ventures's largest investment?

Among tracked funding rounds, G-P/Globalization Partners received $200.0M in a Private Equity round. Sands Capital Ventures's total known invested capital is $4.1B.

What is the average investment size for Sands Capital Ventures?

Sands Capital Ventures's average investment size is $49.9M across its portfolio of 99 companies.

What are Sands Capital Ventures's most recent investments?

Recent Sands Capital Ventures portfolio additions include Red Sift, Nanoview Biosciences, Dreadnode, Speech Graphics, Chronicle Studios. These companies were founded in 2020 or later.

Reach the founders behind these 99 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →